MedPath

APrevent Biotech GmbH

๐Ÿ‡ฆ๐Ÿ‡นAustria
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)โ€ข Click on a phase to view related trials

Not Applicable
2 (100.0%)

APrevent-VOIS-Implant-002 - a Two-Part, Open-Label, Non-Randomized Multicenter Study

Not Applicable
Recruiting
Conditions
Paralysis, Unilateral, Vocal Cord
First Posted Date
2021-11-15
Last Posted Date
2025-02-06
Lead Sponsor
APrevent Biotech GmbH
Target Recruit Count
30
Registration Number
NCT05119842
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Mayo Clinic - Phoenix, Phoenix, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

Greater Baltimore Medical Center, Baltimore, Maryland, United States

๐Ÿ‡บ๐Ÿ‡ธ

Cleveland Clinic, Cleveland, Ohio, United States

and more 4 locations

APrevent Vocal Implant System (VOIS) for Adjustable Treatment of Unilateral Vocal Fold Paralysis (UVFP)

Not Applicable
Completed
Conditions
Paralysis, Unilateral, Vocal Cord
First Posted Date
2019-03-06
Last Posted Date
2019-03-07
Lead Sponsor
APrevent Biotech GmbH
Target Recruit Count
8
Registration Number
NCT03864757
Locations
๐Ÿ‡ฆ๐Ÿ‡น

Medical University of Vienna, Vienna, Austria

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.